540204 — Eiko Lifesciences Income Statement
0.000.00%
Last trade - 00:00
- IN₹679.51m
- IN₹638.74m
- IN₹183.21m
- 24
- 19
- 44
- 14
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final |
Revenue | ||||
Total Revenue | 0 | 120 | 254 | 183 |
Cost of Revenue | ||||
Gross Profit | 0 | 13.8 | 28.3 | 22.3 |
Selling / General / Administrative Expenses | ||||
Depreciation and Amortization | ||||
Other Operating Expenses | ||||
Total Operating Expenses | 2.31 | 115 | 247 | 180 |
Operating Profit | -2.31 | 4.6 | 7.33 | 3.22 |
Total Net Non Operating Interest Income / Expense | ||||
Other Net Non Operating Costs | ||||
Net Income Before Taxes | 1.3 | 8.33 | 9.42 | 10.3 |
Provision for Income Taxes | ||||
Net Income After Taxes | 1.28 | 6.14 | 7.06 | 7.69 |
Net Income Before Extraordinary Items | ||||
Net Income | 1.28 | 6.14 | 7.06 | 7.69 |
Adjustments to Net Income | ||||
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Diluted Net Income | 1.28 | 6.14 | 7.06 | 7.69 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | 0.29 | 1.39 | 0.783 | 0.797 |
Dividends per Share |